Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction. [electronic resource]
Producer: 20180503Description: 2820-2829 p. digitalISSN:- 1526-4602
- Animals
- Chondroitin Sulfates -- chemistry
- Drug Carriers -- adverse effects
- Drug Liberation
- Extracellular Matrix -- drug effects
- Heparin -- chemistry
- Humans
- Hydrogels -- adverse effects
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase Inhibitors -- administration & dosage
- Myocardial Infarction -- drug therapy
- Myocytes, Cardiac -- drug effects
- Peptides, Cyclic -- administration & dosage
- Rats
- Rats, Sprague-Dawley
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.